• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤T细胞淋巴瘤的过继性免疫治疗。

Adoptive immunotherapy for cutaneous T-cell lymphomas.

作者信息

Sastry P S

机构信息

Royal Marsden Hospital, Sutton, Surrey, UK.

出版信息

Med Hypotheses. 1999 Apr;52(4):353-4. doi: 10.1054/mehy.1997.0659.

DOI:10.1054/mehy.1997.0659
PMID:10465675
Abstract

The pathology of cutaneous T-cell lymphomas is predominantly in the skin. Allogeneic bone-marrow transplantation results in graft-versus-host disease involving the skin in many cases. It has been suggested that it would be interesting to see the effect of allotransplantation, even though no series has been reported so far. Adoptive immunotherapy with donor lymphocyte infusions has been increasingly used to treat post-transplant relapse and even prevention. The present hypothesis suggests that infusion of human leucocyte antigen (HLA)-matched donor lymphocyte infusions would result in a graft-versus-leukemia/lymphoma (GVL) effect in these disorders. Therefore, clinical trials are suggested.

摘要

皮肤T细胞淋巴瘤的病理学主要表现在皮肤。在许多情况下,异基因骨髓移植会导致涉及皮肤的移植物抗宿主病。有人提出,尽管目前尚无相关系列报道,但观察同种异体移植的效果可能会很有意思。供体淋巴细胞输注的过继性免疫疗法已越来越多地用于治疗移植后复发甚至预防。目前的假说认为,输注人类白细胞抗原(HLA)匹配的供体淋巴细胞会在这些疾病中产生移植物抗白血病/淋巴瘤(GVL)效应。因此,建议开展临床试验。

相似文献

1
Adoptive immunotherapy for cutaneous T-cell lymphomas.皮肤T细胞淋巴瘤的过继性免疫治疗。
Med Hypotheses. 1999 Apr;52(4):353-4. doi: 10.1054/mehy.1997.0659.
2
Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.供者淋巴细胞输注联合全身 PUVA/贝沙罗汀作为一种有效的双模态免疫方法,用于异基因干细胞移植后复发的皮肤 T 细胞淋巴瘤患者。
Transpl Immunol. 2011 Sep;25(2-3):163-6. doi: 10.1016/j.trim.2011.06.008. Epub 2011 Jul 2.
3
Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation.
Bone Marrow Transplant. 2004 Sep;34(6):521-5. doi: 10.1038/sj.bmt.1704641.
4
[Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy].[异基因造血干细胞移植(HSCT)后同种异体反应性供体淋巴细胞(DLI):毒性和疗效研究]
Bull Cancer. 2003 Aug-Sep;90(8-9):758-62.
5
Cutaneous T cell lymphoma: the helping hand of dendritic cells.皮肤T细胞淋巴瘤:树突状细胞的助力
Ann N Y Acad Sci. 2001 Sep;941:1-11.
6
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
7
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.小鼠B细胞白血病(BCL1)中的异基因细胞疗法:1. 来自不同淋巴区室的未修饰和体外经重组白细胞介素-2激活的骨髓及淋巴细胞诱导的同种免疫介导的移植物抗白血病(GVL)效应。
Cytokines Cell Mol Ther. 1999 Sep;5(3):145-52.
8
Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.使用故意不匹配的供体淋巴细胞诱导移植后早期移植物抗白血病效应,并清除同种抗原致敏的供体淋巴细胞以预防移植物抗宿主病。
Cancer Res. 2005 Nov 1;65(21):9735-40. doi: 10.1158/0008-5472.CAN-04-4175.
9
Cell therapy: achievements and perspectives.细胞疗法:成就与展望。
Haematologica. 1999 Dec;84(12):1110-49.
10
Graft-versus-T-cell non-Hodgkin's lymphoma effect.移植物抗T细胞非霍奇金淋巴瘤效应
Int J Hematol. 2006 Apr;83(3):193. doi: 10.1532/IJH97.05176.